FEBS Letters | |
Stereospecific antibodies to propranolol | |
Levitzki, Alexander2  Feingers, Judith3  Inbar, Michael3  Wang, Lynn3  Chorev, Michael1  | |
[1] Department of Pharmaceutical Chemistry, School of Pharmacy, The Hebrew University of Jerusalem, 91120 JerusalemIsrael;Department of Biological Chemistry, Institute of Life Sciences, The Hebrew University of Jerusalem, 91904 Jerusalem, Israel;International Diagnostic Laboratories, PO Box 5577, Jerusalem, Israel | |
关键词: Propranolol; Monoclonal antibody; Stereospecificity; β-Adrenergic receptor; β-Adrenergic antagonist; | |
DOI : 10.1016/0014-5793(86)80474-4 | |
学科分类:生物化学/生物物理 | |
来源: John Wiley & Sons Ltd. | |
【 摘 要 】
The β-adrenergic antagonist propranolol was activated through its side chain, coupled to bovine serum albumin, and injected into BALB/c mice. After fusion of the splenocytes from these immunized mice with the NS-1 myeloma cell line, two hybridomas, producing monoclonal anti-propranolol antibodies, were isolated. Clone P-49 was monospecific for propranolol, with a significant preference for the 1-stereoisomer, as compared to the d form. On the other hand, clone P-28 cross-reacted with alprenolol as well as some other β-antagonists. Both classes of antibodies competed with A431 epidermoid carcinoma β2-adrenoceptors for the binding of [3H]propranolol. When ascites cells from clone P-28 were fixed with glutaraldehyde, the anti-propranolol monoclonal antibody became cell bound. These cell-bound P-28 antibodies bind propranolol and other β-adrenergic ligands with a similar ranking order to the soluble monoclonal antibody. The cell-bound antibody displayed a 5-fold higher affinity towards 1-propranolol than the soluble monoclonal antibody. The practical implications of these findings are discussed.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201912020287916ZK.pdf | 592KB | download |